Related Experiment Videos
The what, why and how of hypertensive heart disease
1Department of Internal Medicine, University of Missouri Health Sciences Centre, Columbia 65212.
Insights
Left ventricular hypertrophy is a key risk factor for cardiovascular events like heart attack and stroke. This review explores hypertensive heart disease, its causes, and prevention strategies.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiovascular Pathophysiology
Background:
- Left ventricular hypertrophy (LVH) is a significant risk factor for adverse cardiovascular outcomes.
- LVH is prevalent in both the general population and individuals with uncomplicated hypertension.
- Hypertensive heart disease (HHD) encompasses the cardiac consequences of elevated blood pressure.
Purpose of the Study:
- To review the definition, pathophysiology, and clinical implications of hypertensive heart disease (HHD).
- To elucidate the mechanisms underlying myocardial structural remodeling in response to hypertension.
- To discuss current strategies for the prevention and regression of HHD.
Main Methods:
- Review of clinical and experimental studies.
- Analysis of data on cardiovascular events associated with LVH.
- Examination of etiological factors and therapeutic interventions for HHD.
Main Results:
- LVH is strongly linked to increased risk of myocardial infarction, heart failure, stroke, and sudden cardiac death.
- Hypertension is a primary driver of pathological myocardial remodeling.
- Preventive and regression strategies for HHD are crucial for mitigating cardiovascular risk.
Conclusions:
- Hypertensive heart disease represents a major clinical challenge.
- Understanding the pathophysiology of LVH is essential for effective management.
- Interventions targeting hypertension can prevent or reverse cardiac structural changes.
Abstract:
Left ventricular hypertrophy is now recognised to be an important risk factor associated with such adverse cardiovascular events as myocardial infarction, heart failure, stroke and sudden cardiac death. This is true for the general population and those with uncomplicated hypertension. Herein the what, why and how of hypertensive heart disease (HHD) is reviewed: what is it, why does a structural remodelling of the myocardium occur and how can it be prevented on the one hand or regressed on the other. Clinical and experimental studies are presented to address each of these issues.